- Vitamin D3 intake as modulator for the early biomarkers of myocardial tissue injury in diabetic hyperlipidaemic rats
Archives of Physiology and Biochemistry · 2020
- Unexpected Troponin Elevation in a Patient Treated with Atorvastatin
The Journal of Applied Laboratory Medicine · 2020
- Familial hypercholesterolemia: Detect, treat, and ask about family
Cleveland Clinic Journal of Medicine · 2020
- Nucleic Acid–Based Therapies for Atherosclerosis
Current Atherosclerosis Reports · 2020
- Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study
European Heart Journal · 2020
- Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries
Cardiovascular Therapeutics · 2020
- Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial
TH Open · 2020
- Apixaban versus Warfarin in Patients with Left Ventricular Thrombus: A Pilot Prospective Randomized Outcome Blinded Study Investigating Size Reduction or Resolution of Left Ventricular Thrombus
Journal of Clinical and Preventive Cardiology · 2020
- Does Extended Use of Clopidogrel-Based Dual Anti-Platelet Therapy Increase the Risk of Gastrointestinal Bleeding?
Gastroenterology Research · 2020
- Successful treatment of cholesterol crystal embolism with anti-proprotein convertase subtilisin/kexin type 9 (PCSK9) antibody: a case report
Renal Failure · 2020
- Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK
Journal of Market Access & Health Policy · 2020
- The Effect of Atorvastatin on the Common Carotid Artery Intima-Media Thickness in Patients with Ischemic Stroke
Acta Clinica Croatica · 2020
- Effects of Lipid Lowering Drugs on Arterial Stiffness: One More Way to Reduce Cardiovascular Risk?
Current Vascular Pharmacology · 2019
- Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells Combined with Atorvastatin for Acute Myocardial Infarction (TEAM-AMI): Rationale and Design of a Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II TEAM-AMI Trial
Regenerative Medicine · 2019
- Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation
Rational Pharmacotherapy in Cardiology · 2019
- Effects of atorvastatin on time-dependent change of fast sodium current in simulated acute ischaemic ventricular myocytes
Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · 2019
- An evaluation of rivaroxaban and clopidogrel in a rat lower extremity ischemia-reperfusion model: An experimental study
Turkish Journal of Thoracic and Cardiovascular Surgery · 2019
- Gender Disparities in Health Resource Utilization in Patients with Atherosclerotic Cardiovascular Disease: A Retrospective Cross-Sectional Study
Advances in Therapy · 2019
- Proprotein convertase subtilisin/kexin type 9 inhibitors and lipoprotein(a)-mediated risk of atherosclerotic cardiovascular disease: more than meets the eye?
Current Opinion in Lipidology · 2019
- <p>Differences In Gastrointestinal Safety Profiles Among Novel Oral Anticoagulants: Evidence From A Network Meta-Analysis</p>
Clinical Epidemiology · 2019
- Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation
Journal of Stroke · 2019
- PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: Benefits beyond lipid‐lowering effects
Journal of Cellular and Molecular Medicine · 2019
- N-acetylcysteine and atorvastatin alleviates lung injury due to ischemia-reperfusion injury in rats
Journal of the Chinese Medical Association · 2019
- Polypill for Cardiovascular Disease Prevention in an Underserved Population
New England Journal of Medicine · 2019
- Preprocedural high - sensitivity C-reactive protein (hsCRP) decrease during intensive atorvastatin therapy: the presumable impact on atherosclerosis progression after coronary stenting
Terapevticheskii arkhiv · 2019
- Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
Circulation · 2019
- Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)
Journal of the American College of Cardiology · 2019
- Pharmacokinetic Properties of Rivaroxaban in Healthy Human Subjects
Cureus · 2019
- A Review of PCSK9 Inhibitors and their Effects on Cardiovascular Diseases
Current Topics in Medicinal Chemistry · 2019
- Pharmacokinetic and Safety Profiles of a Fixed‐Dose Combination of Amlodipine, Valsartan, and Atorvastatin: A 3‐Period Replicate Crossover Study
Clinical Pharmacology in Drug Development · 2019
- Atorvastatin improves the cardiac function of rats after acute myocardial infarction through ERK1/2 pathway.
European review for medical and pharmacological sciences · 2019
- Alirocumab in Acute Myocardial Infarction: Results From the Virginia Commonwealth University Alirocumab Response Trial (VCU-AlirocRT)
Journal of Cardiovascular Pharmacology · 2019
- Atorvastatin attenuates cardiac hypertrophy through AMPK/miR-143-3p/Bcl2 axis
Archives of Physiology and Biochemistry · 2019
- Association of Region and Hospital and Patient Characteristics With Use of High-Intensity Statins After Myocardial Infarction Among Medicare Beneficiaries
JAMA Cardiology · 2019
- Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia
BMC Research Notes · 2019
- Intravenous Statin Administration During Ischemia Exerts Cardioprotective Effects
Journal of the American College of Cardiology · 2019
- ASPECTS OF MULTICOMPONENT THERAPY AND PERIOPERATIVE TACTICS IN A PATIENT WITH ATRIAL FIBRILLATION RECEIVING RIVAROXABAN THERAPY. CLINICAL OBSERVATION
Aterotromboz = Atherothrombosis · 2019
- Optimization of Timing and Times for Administration of Atorvastatin-Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction
Stem Cells Translational Medicine · 2019
- Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Diabetes & Metabolism Journal · 2019
- Statins exacerbate glucose intolerance and hyperglycemia in a high sucrose fed rodent model
Scientific Reports · 2019
- Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study
Research and Practice in Thrombosis and Haemostasis · 2019
- Statins Reduce Epicardial Adipose Tissue Attenuation Independent of Lipid Lowering: A Potential Pleiotropic Effect
Journal of the American Heart Association · 2019
- Ginkgolide B Mediated Alleviation of Inflammatory Cascades and Altered Lipid Metabolism in HUVECs via Targeting PCSK-9 Expression and Functionality
BioMed Research International · 2019
- Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials
Atherosclerosis · 2019
- Impact of Cancer on Bleeding and Ischemic Stroke in Atrial Fibrillation Patients Taking Rivaroxaban, a Direct Oral Anticoagulant
2019
- Idarucizumab to revert the anticoagulant effect of dabigatran in traumatic acute subdural haematoma: a case report of first use in Latin America
European Heart Journal - Case Reports · 2019
- Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial
Journal of the American College of Cardiology · 2019
- Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease
JAMA Cardiology · 2019
- Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19
Cardiovascular Research · 2019
- Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?
Clinical Kidney Journal · 2019